BlueCross BlueShield of South Carolina is announcing some minor updates in its pharmacy policies, including approval of a new glucose monitoring device and additions to some of its drug lists. Most of the changes take effect on Oct. 1, 2018.

We work with an independent panel of BlueCross network physicians and pharmacists, the Pharmacy and Therapeutics Committee, to develop and maintain our drug lists and policies. Clinical decisions are based on drugs’ efficacy, safety and value, with the goal of providing the greatest clinical effectiveness for the lowest cost.

In some cases, member notifications are planned. Please see the Pharmacy department’s bulletin for details.

For more information, please contact your BlueCross Major Group representative.